Merrell Dow
Executive Summary
Firm announced that it is investing $25 mil. to expand research facilities at Merrell Dow Research Institute in Cincinnati. Two new buildings, the first to be completed in October 1985 and the second in mid-1987, will house research focusing "on rapidly evolving areas such as molecular biology, the structure and functions of proteins and on enzyme biochemistry," the firm said. Expansion is expected to add 200 new research and support personnel jobs
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.